Treatment of oromandibular dystonia using botulinum toxin injections - Case series and illustrative muscle targeting

被引:4
|
作者
Yu, Genevieve Lynn Tan [1 ]
Rosales, Raymond L. [1 ]
机构
[1] Univ Santo Tomas Hosp, Dept Neurol & Psychiat, Manila, Philippines
关键词
Oromandibular dystonia; Botulinum toxin; Muscle selection;
D O I
10.1016/j.baga.2018.05.002
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Oromandibular dystonia (OMD) is a severely disabling disorder with limited available therapies. Current oral medications for OMD are ineffective and may pose further risks of aspiration particularly in combination states of jaw and tongue dystonia. We advocate the use of Botulinum neurotoxin (BoNT) injection with proper muscle site selection and dosing as the most effective treatment in OMD clinically. Targeting muscle for injection should involve not only an astute clinical examination and understanding the patient's history, but perhaps also guided by instrumentation. Based on our previous and present case series, we present specific localization techniques for BoNT in OMD patients subsequent to methodical patient selection, proper BoNT reconstitution and conversion. We believe adequate knowledge and appropriate technique will give our patients greatest benefit and will minimize risk of adverse events following treatment.
引用
收藏
页码:7 / 16
页数:10
相关论文
共 50 条
  • [31] Botulinum Toxin Injections as a Treatment of Refractory Vulvodynia in Adolescents: A Case Series
    Bhuiyan, Julia
    Habeshian, Kaiane A.
    Booser, Adam C.
    Gomez-Lobo, Veronica
    Dowlut-McElroy, Tazim
    JOURNAL OF PEDIATRIC AND ADOLESCENT GYNECOLOGY, 2023, 36 (05) : 497 - 500
  • [32] Secondary nonresponsiveness to botulinum toxin type A in patients with oromandibular dystonia
    Adler, CH
    Factor, SA
    Brin, M
    Sethi, KD
    MOVEMENT DISORDERS, 2002, 17 (01) : 158 - 161
  • [33] Oromandibular dystonia as psychosomatic disorder following botulinum toxin A injection
    Sugimoto, K.
    Sugimoto, K.
    ORAL DISEASES, 2010, 16 (06) : 568 - 568
  • [34] Botulinum Toxin B for patients with oromandibular dystonia resistant to Botulinum Toxin A: Report of four cases
    Catania, S
    Cordivari, C
    Misra, P
    Lees, A
    MOVEMENT DISORDERS, 2004, 19 : S96 - S96
  • [35] Oromandibular Dystonia: Long-Term Management With Botulinum Toxin
    Sinclair, Catherine F.
    Gurey, Lowell E.
    Blitzer, Andrew
    LARYNGOSCOPE, 2013, 123 (12): : 3078 - 3083
  • [36] Botulinum toxin a for oromandibular dystonia: Individualized approach and clinical experience
    Youssry, D.
    Alhashel, J.
    JOURNAL OF THE NEUROLOGICAL SCIENCES, 2019, 405
  • [37] The Effects of Botulinum Toxin in Oromandibular Dystonia, a Meta-analysis
    Asuncion, Ria Monica
    Rosales, Raymond
    MOVEMENT DISORDERS, 2016, 31 : S72 - S73
  • [38] Botulinum toxin-responsive oromandibular dystonia in cerebrotendinous xanthomatosis
    Posada, Ignacio J.
    Ramos, Ana
    PARKINSONISM & RELATED DISORDERS, 2011, 17 (07) : 570 - 572
  • [39] Treatment of Blepharospasm and Oromandibular Dystonia with Botulinum Toxins
    Hassell, Travis J. W.
    Charles, David
    TOXINS, 2020, 12 (04)
  • [40] Botulinum toxins in the treatment of laryngeal and oromandibular dystonia
    Hawthorne, M
    OPTIMAL PATIENT MANAGEMENT WITH BOTULINUM TOXINS: EVIDENCE AND EXPERIENCE, 2002, (74): : 40 - 46